LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.

    Feigerlova, Eva / Swinyard, Mike / Derr, Michael A / Farnsworth, Jeannie / Andrew, Shayne F / Rosenfeld, Ron G / Hwa, Vivian

    Hormone research in paediatrics

    2013  Volume 80, Issue 6, Page(s) 397–405

    Abstract: Background/aims: Mutations in the human growth hormone receptor gene (GHR) are the most common cause of growth hormone insensitivity (GHI) syndrome and insulin-like growth factor (IGF-1) deficiency. The extracellular domain of GHR (encoded by exons 2-7 ... ...

    Abstract Background/aims: Mutations in the human growth hormone receptor gene (GHR) are the most common cause of growth hormone insensitivity (GHI) syndrome and insulin-like growth factor (IGF-1) deficiency. The extracellular domain of GHR (encoded by exons 2-7 of the GHR gene) can be proteolytically cleaved to circulate as GH-binding protein (GHBP).
    Methods: We evaluated the cause of classical GHI (Laron) phenotypes in 3 siblings.
    Results: Two brothers (aged 16.5 and 14.9 years) and their half-brother (aged 11.3 years) presented with extreme short stature (height standard deviation score, SDS, of -7.05, -6.34 and -8.02, respectively). The parents were consanguineous and of normal stature. Serum GHBP levels of probands were undetectable and circulating IGF-1 and IGF-binding protein-3 were abnormally low, but GH concentrations were elevated. Molecular analysis of the GHR gene revealed homozygous deletion of exon 3, a common polymorphism, and a novel c.266+83G>T variant within intron 4 which generated a 5' donor splice site. Splicing events from this cryptic 5' donor site resulted in retention of 81 intronic nucleotides in the GHR mRNA. Long-term rhIGF-1 therapy combined with leuprolide depot increased height by +2 to +3 SDS.
    Conclusion: The c.266+83G>T is the second intronic GHR mutation identified that activates a cryptic 5' donor splice site. The abnormal splicing event led to early protein termination and undetectable serum GHBP concentrations. © 2013 S. Karger AG, Basel.
    MeSH term(s) Adolescent ; Base Sequence ; Child ; Humans ; Insulin-Like Growth Factor I/therapeutic use ; Introns/genetics ; Laron Syndrome/drug therapy ; Laron Syndrome/genetics ; Male ; Molecular Sequence Data ; Pedigree ; Polymorphism, Single Nucleotide ; RNA Splice Sites/genetics ; Receptors, Somatotropin/genetics ; Severity of Illness Index ; Siblings
    Chemical Substances RNA Splice Sites ; Receptors, Somatotropin ; Insulin-Like Growth Factor I (67763-96-6)
    Language English
    Publishing date 2013
    Publishing country Switzerland
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2537278-6
    ISSN 1663-2826 ; 1663-2818
    ISSN (online) 1663-2826
    ISSN 1663-2818
    DOI 10.1159/000355404
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: A Novel ; Intronic Variant, ; , Activates a Cryptic 5′ Splice Site Causing Severe GHR Deficiency and Classical GH Insensitivity Syndrome

    Feigerlova, Eva / Swinyard, Mike / Derr, Michael A. / Farnsworth, Jeannie / Andrew, Shayne F. / Rosenfeld, Ron G. / Hwa, Vivian

    Hormone Research in Paediatrics

    2013  Volume 80, Issue 6, Page(s) 397–405

    Abstract: Background/Aims: Mutations in the human growth hormone receptor gene (GHR) are the most common cause of growth hormone insensitivity (GHI) syndrome and insulin-like growth factor (IGF-1) deficiency. The extracellular domain of GHR (encoded by exons 2-7 ... ...

    Institution Department of Pediatrics, Oregon Health and Science University, Portland, Oreg Mountain Vista Medicine PC, South Jordan, Utah, USA Service d'Endocrinologie, Centre Hospitalier Régional et Universitaire, Vandoeuvre-lès-Nancy, France
    Abstract Background/Aims: Mutations in the human growth hormone receptor gene (GHR) are the most common cause of growth hormone insensitivity (GHI) syndrome and insulin-like growth factor (IGF-1) deficiency. The extracellular domain of GHR (encoded by exons 2-7 of the GHR gene) can be proteolytically cleaved to circulate as GH-binding protein (GHBP). Methods: We evaluated the cause of classical GHI (Laron) phenotypes in 3 siblings. Results: Two brothers (aged 16.5 and 14.9 years) and their half-brother (aged 11.3 years) presented with extreme short stature (height standard deviation score, SDS, of -7.05, -6.34 and -8.02, respectively). The parents were consanguineous and of normal stature. Serum GHBP levels of probands were undetectable and circulating IGF-1 and IGF-binding protein-3 were abnormally low, but GH concentrations were elevated. Molecular analysis of the GHR gene revealed homozygous deletion of exon 3, a common polymorphism, and a novel c.266+83G>T variant within intron 4 which generated a 5′ donor splice site. Splicing events from this cryptic 5′ donor site resulted in retention of 81 intronic nucleotides in the GHR mRNA. Long-term rhIGF-1 therapy combined with leuprolide depot increased height by +2 to +3 SDS. Conclusion: The c.266+83G>T is the second intronic GHR mutation identified that activates a cryptic 5′ donor splice site. The abnormal splicing event led to early protein termination and undetectable serum GHBP concentrations.
    Keywords Growth hormone insensitivity syndrome ; Growth hormone receptor splicing mutation ; Growth hormone receptor deficiency
    Language English
    Publishing date 2013-11-26
    Publisher S. Karger AG
    Publishing place Basel, Switzerland
    Document type Article
    Note Further Section
    ZDB-ID 2537278-6
    ISBN 978-3-318-02616-0 ; 978-3-318-02617-7 ; 3-318-02616-6 ; 3-318-02617-4
    ISSN 1663-2826 ; 1663-2818
    ISSN (online) 1663-2826
    ISSN 1663-2818
    DOI 10.1159/000355404
    Database Karger publisher's database

    More links

    Kategorien

To top